Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 Infection—Reply

Rong Xu,Nathan A. Berger,QuanQiu Wang
DOI: https://doi.org/10.1001/jamaoncol.2021.0771
IF: 33.006
2021-07-01
JAMA Oncology
Abstract:<span><strong>In Reply</strong> We appreciate the thoughtful comments by Wolfson et al regarding our case-control study.<sup><a class="ref-link section-jump-link" href="#clr210009r1">1</a></sup> Our study showed that patients with cancer were at increased risk for COVID-19 infection compared with patients without cancer. We avoided deriving strong conclusions regarding the direct associations among cancers, COVID-19 susceptibility, and severe outcomes owing to inherent limitations of using patient electronic health record (EHR) data, including unmeasured confounding factors, limited time-series information, limited information on socioeconomic and lifestyle determinants, and lack of finer-grained information of admitting diagnoses of hospitalization and contributing causes of death, among others.</span>
oncology
What problem does this paper attempt to address?